Global Safety Syringes Market is valued at approximately USD 7096.94 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.5% during the forecast period 2023-2030. Safety Syringes are specialized medical devices designed to enhance the safety of healthcare workers and patients during the administration of injections or the drawing of blood. These syringes incorporate various safety features to minimize the risk of accidental needlestick injuries and the potential transmission of bloodborne pathogens. The Safety Syringes Market is expanding because of factors such as rising demand for minimally invasive surgeries and increasing prevalence of diabetes. As a result, the demand for Safety Syringes has progressively increased in the international market during the forecast period 2023-2030.

Minimally invasive surgeries often involve multiple needle-related tasks, such as inserting catheters, delivering medications, or drawing blood and the growing demand for minimally invasive surgeries leads to increased regulatory focus on safety measures, including the use of safety syringes. Which requires healthcare facilities to implement safety protocols and adopt safety devices to minimize the risk of injuries during these procedures. According to Statista, the global minimally Invasive Surgery Market was valued at over USD 20.5 billion in 2019 and is projected to grow up to USD 44 billion by the year 2030. Furthermore, the global minimally Invasive Surgical System Market was valued at roughly USD 29 billion in 2021 and is expected to grow to more than USD 55 billion by the year 2030. Another important factor that drives the Safety Syringes Market is the increasing prevalence of diabetes. Many individuals with diabetes require insulin therapy to manage their condition. The need for frequent insulin injections increases the overall demand for safe syringes. In addition, as per the International Diabetes Federation, in 2021, 537 million adults were diagnosed with diabetes and projected to reach up to 643 million in number by 2030 and 783 million adults by the year 2045. Moreover, rising government expenditure towards healthcare infrastructure and growing awareness of infectious diseases are anticipated to create lucrative growth opportunities for the market over the forecast period. However, cost considerations and lack of regulatory standards are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Safety Syringes Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high disposable income, high healthcare expenditure, and well-developed healthcare sector in the region. High disposable income in a population allows individuals and healthcare facilities to afford the costs associated with advanced medical technologies, including safe syringes. This increased affordability can lead to a higher rate of adoption among healthcare providers and facilities. The region's dominant performance is anticipated to propel the overall demand for Safety Syringes. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as supportive government initiatives towards healthcare infrastructure in the region. Government initiatives often include public health campaigns to raise awareness about the importance of safety in healthcare practices. Campaigns that emphasize the risks associated with needlestick injuries and promote the use of safe syringes contribute to increased awareness and adoption among healthcare professionals.

Major market player included in this report are:
Becton, Dickinson and Company
Smith's Medical, Inc.
Cardinal Health Inc.
DMC Medical Ltd
Unilife Corporation
Fresenius Kabi AG
Kendall Healthcare Pvt. Ltd
Retractable Technologies, Inc
Medline Industries Lp
Nipro Corporation
Recent Developments in the Market:
In November 2021, Becton, Dickinson and Company, a leading global medical technology firm introduced the BD UltraSafe Plus 2.25 mL Passive Needle Guard. This innovative product is designed for utilization by pharmaceutical companies in the development of drug-device combination products. Specifically, when paired with a Glass Prefillable Syringe, the BD UltraSafe Plus 2.25 mL system facilitates the subcutaneous delivery of biologic solutions with varying fill volumes up to 2 mL and viscosities reaching up to 30 cP. The BD UltraSafe Plus 2.25 mL system addresses the requirements of healthcare providers, patients, and caregivers involved in the manual administration of biological solutions. Its distinctive design caters to the strategies of bio-pharmaceutical companies by offering patient-controlled injection options, especially beneficial for the delivery of complex, high-viscosity drugs.
Global Safety Syringes Market Report Scope:
Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Distribution Channel, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Product
Retractable
Non-retractable
by Application
Subcutaneous
Intramuscular
by Distribution Channel
Direct to Customer (DTC)
Retail Sales
Online Pharmacies
by End-user
Hospitals
Ambulatory Surgical Centers
Long-term Care Facilities
Specialty Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa